![W. Bradley Yale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
W. Bradley Yale
Directeur/Membre du Conseil chez
U.S. Anesthesia Partners, Inc.
Profil
Mr. Bradley Yale is a Principal at BC Partners, Inc.
Prior to joining BC Partners in 2008, Mr. Yale was employed as an Analyst by Morgan Stanley.
Mr. Yale earned his BS in Operations Research and Industrial Engineering MEng in Financial Engineering from Cornell University.
Postes actifs de W. Bradley Yale
| Sociétés | Poste | Début |
|---|---|---|
U.S. Anesthesia Partners, Inc.
 U.S. Anesthesia Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides practice management services to anesthesiologists | Directeur/Membre du Conseil | - |
Anciens postes connus de W. Bradley Yale
| Sociétés | Poste | Fin |
|---|---|---|
BC Partners, Inc.
 BC Partners, Inc. Investment ManagersFinance BC Partners focuses on leading buy-outs of larger businesses in the region and selectively outside Europe through its established network of offices in London, Paris, Hamburg, Milan and New York. The firm is an active, long-term manager that concentrates on large, multi-country transactions which typically have significant operations in Europe even when the principal place of business is elsewhere. They target a small number of companies, seeking a seat on the board of directors and partnering with management to implement the business plan and identify opportunities for value creation. BC Partners typically invests in high quality businesses which enjoy strong competitive positions in their industry. They focus on business fundamentals rather than sector specialization, placing particular value on pricing or cost leadership, demonstrated resilience to cycle downturns, profit improvement potential, and a high quality management team. The firm can invest over €2 billion per transaction and can contribute significant financial reserves to grow an acquired business. | Analyste en capital-investissement | 01/01/2014 |
| MORGAN STANLEY | Corporate Officer/Principal | 01/01/2008 |
| ADT INC. | Directeur/Membre du Conseil | - |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Directeur/Membre du Conseil | - |
Formation de W. Bradley Yale
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BC Partners, Inc.
BC Partners, Inc. Investment ManagersFinance BC Partners focuses on leading buy-outs of larger businesses in the region and selectively outside Europe through its established network of offices in London, Paris, Hamburg, Milan and New York. The firm is an active, long-term manager that concentrates on large, multi-country transactions which typically have significant operations in Europe even when the principal place of business is elsewhere. They target a small number of companies, seeking a seat on the board of directors and partnering with management to implement the business plan and identify opportunities for value creation. BC Partners typically invests in high quality businesses which enjoy strong competitive positions in their industry. They focus on business fundamentals rather than sector specialization, placing particular value on pricing or cost leadership, demonstrated resilience to cycle downturns, profit improvement potential, and a high quality management team. The firm can invest over €2 billion per transaction and can contribute significant financial reserves to grow an acquired business. | Finance |
U.S. Anesthesia Partners, Inc.
U.S. Anesthesia Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides practice management services to anesthesiologists | Commercial Services |
ADT, Inc.
 ADT, Inc. Miscellaneous Commercial ServicesCommercial Services Provides monitored security, interactive home and business automation and related monitoring services | Commercial Services |
Choisissez Zonebourse 
